Published in Am J Pathol on September 01, 2005
Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature (2014) 4.00
Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature (2012) 3.63
Lentiviral vectors and protocols for creation of stable hESC lines for fluorescent tracking and drug resistance selection of cardiomyocytes. PLoS One (2009) 2.62
Systems approaches to preventing transplanted cell death in cardiac repair. J Mol Cell Cardiol (2008) 2.60
Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. Stem Cells Dev (2013) 2.24
Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. J Exp Med (2006) 2.23
Cardiopoietic programming of embryonic stem cells for tumor-free heart repair. J Exp Med (2007) 1.97
Assessment and optimization of cell engraftment after transplantation into the heart. Circ Res (2010) 1.90
Human embryonic stem cell transplantation to repair the infarcted myocardium. Heart (2007) 1.86
Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in rats. J Mol Cell Cardiol (2010) 1.75
Simple and high yielding method for preparing tissue specific extracellular matrix coatings for cell culture. PLoS One (2010) 1.60
VEGF induces differentiation of functional endothelium from human embryonic stem cells: implications for tissue engineering. Arterioscler Thromb Vasc Biol (2009) 1.57
A tissue engineering approach to progenitor cell delivery results in significant cell engraftment and improved myocardial remodeling. Stem Cells (2007) 1.53
Empowering self-renewal and differentiation: the role of mitochondria in stem cells. J Mol Med (Berl) (2010) 1.47
Engraftment of human embryonic stem cell derived cardiomyocytes improves conduction in an arrhythmogenic in vitro model. J Mol Cell Cardiol (2012) 1.45
Molecular characterization and functional properties of cardiomyocytes derived from human inducible pluripotent stem cells. J Cell Mol Med (2011) 1.43
Scaffold-free human cardiac tissue patch created from embryonic stem cells. Tissue Eng Part A (2009) 1.42
Efficient generation and cryopreservation of cardiomyocytes derived from human embryonic stem cells. Regen Med (2011) 1.35
Cell-based therapy for prevention and reversal of myocardial remodeling. Am J Physiol Heart Circ Physiol (2012) 1.31
Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat hearts. J Mol Cell Cardiol (2007) 1.23
Natural and synthetic regulators of embryonic stem cell cardiogenesis. Pediatr Cardiol (2009) 1.20
c-kit+ Cardiac stem cells alleviate post-myocardial infarction left ventricular dysfunction despite poor engraftment and negligible retention in the recipient heart. PLoS One (2014) 1.20
Chromatin remodeling during mouse and human embryonic stem cell differentiation. Dev Dyn (2008) 1.18
Cardiac regeneration. Curr Top Dev Biol (2012) 1.17
A highly sensitive and accurate method to quantify absolute numbers of c-kit+ cardiac stem cells following transplantation in mice. Basic Res Cardiol (2013) 1.17
A chemical biology approach to myocardial regeneration. J Cardiovasc Transl Res (2011) 1.17
Cardiac repair and regeneration: the Rubik's cube of cell therapy for heart disease. Dis Model Mech (2009) 1.16
Human embryonic stem cells and cardiac repair. Transplant Rev (Orlando) (2008) 1.15
Preconditioning stem cells for in vivo delivery. Biores Open Access (2014) 1.09
Cardiac differentiation of pluripotent stem cells. Stem Cells Int (2011) 1.09
Human embryonic stem cells differentiated to lung lineage-specific cells ameliorate pulmonary fibrosis in a xenograft transplant mouse model. PLoS One (2012) 1.08
Injectable cardiac tissue engineering for the treatment of myocardial infarction. J Cell Mol Med (2010) 1.08
beta(1)- and beta(2)-adrenoceptor responses in cardiomyocytes derived from human embryonic stem cells: comparison with failing and non-failing adult human heart. Br J Pharmacol (2008) 1.07
Heart repair and stem cells. J Physiol (2006) 1.04
Cardiac regeneration using human embryonic stem cells: producing cells for future therapy. Regen Med (2010) 1.03
Cardiogenesis from human embryonic stem cells. Circ J (2010) 1.00
Extracellular matrix formation after transplantation of human embryonic stem cell-derived cardiomyocytes. Cell Mol Life Sci (2009) 1.00
PlGF repairs myocardial ischemia through mechanisms of angiogenesis, cardioprotection and recruitment of myo-angiogenic competent marrow progenitors. PLoS One (2011) 0.99
Stem cells for heart cell therapies. Tissue Eng Part B Rev (2008) 0.98
Timed inhibition of p38MAPK directs accelerated differentiation of human embryonic stem cells into cardiomyocytes. Cytotherapy (2010) 0.97
Cardiac applications for human pluripotent stem cells. Curr Pharm Des (2009) 0.97
Cardiac stem cell therapy for cardiac repair. Curr Treat Options Cardiovasc Med (2014) 0.96
Considerations for pre-clinical models and clinical trials of pluripotent stem cell-derived cardiomyocytes. Stem Cell Res Ther (2014) 0.95
Effects of histocompatibility and host immune responses on the tumorigenicity of pluripotent stem cells. Semin Immunopathol (2011) 0.94
Proteomic profiling of cardiac tissue by isolation of nuclei tagged in specific cell types (INTACT). Development (2014) 0.92
Regenerating functional heart tissue for myocardial repair. Cell Mol Life Sci (2012) 0.92
Concise review: cell therapy and tissue engineering for cardiovascular disease. Stem Cells Transl Med (2012) 0.90
Lessons for cardiac regeneration and repair through development. Trends Mol Med (2010) 0.89
Current stem cell delivery methods for myocardial repair. Biomed Res Int (2012) 0.89
Heme oxygenase-1 induction enhances cell survival and restores contractility to unvascularized three-dimensional adult cardiomyocyte grafts implanted in vivo. Tissue Eng Part A (2011) 0.89
Strategies for ensuring that regenerative cardiomyocytes function properly and in cooperation with the host myocardium. Exp Mol Med (2010) 0.89
Organotypic heart slices for cell transplantation and physiological studies. Organogenesis (2009) 0.88
Regenerative medicine for the heart: perspectives on stem-cell therapy. Antioxid Redox Signal (2014) 0.87
Cardiac regeneration using pluripotent stem cells--progression to large animal models. Stem Cell Res (2014) 0.86
Evidence that gene activation and silencing during stem cell differentiation requires a transcriptionally paused intermediate state. PLoS One (2011) 0.85
Vascular potential of human pluripotent stem cells. Arterioscler Thromb Vasc Biol (2010) 0.85
Cell-based delivery of dATP via gap junctions enhances cardiac contractility. J Mol Cell Cardiol (2014) 0.84
Cell transplantation for cardiac regeneration: where do we stand? Neth Heart J (2008) 0.84
Stem cell differentiation: cardiac repair. Cells Tissues Organs (2007) 0.84
Stem cell therapy for cardiac repair. J Cardiovasc Nurs (2009) 0.84
Stem cell therapy for ischemic heart disease. Antioxid Redox Signal (2010) 0.84
Regulation of cardiomyocyte differentiation of embryonic stem cells by extracellular signalling. Cell Mol Life Sci (2007) 0.84
Can mesenchymal stem cells induce tolerance to cotransplanted human embryonic stem cells? Mol Ther (2008) 0.84
Human pluripotent stem cells: Prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repair. Adv Drug Deliv Rev (2015) 0.83
Pre-transplantation specification of stem cells to cardiac lineage for regeneration of cardiac tissue. Stem Cell Rev (2009) 0.83
Isoflurane decreases death of human embryonic stem cell-derived, transcriptional marker Nkx2.5(+) cardiac progenitor cells. Acta Anaesthesiol Scand (2011) 0.83
Forced expression of the cell cycle inhibitor p57Kip2 in cardiomyocytes attenuates ischemia-reperfusion injury in the mouse heart. BMC Physiol (2008) 0.83
Pluripotent stem cell derived cardiomyocytes for cardiac repair. Curr Treat Options Cardiovasc Med (2014) 0.82
Pluripotent stem cells for cardiac regeneration: overview of recent advances & emerging trends. Indian J Med Res (2013) 0.82
Cobalt protoporphyrin pretreatment protects human embryonic stem cell-derived cardiomyocytes from hypoxia/reoxygenation injury in vitro and increases graft size and vascularization in vivo. Stem Cells Transl Med (2014) 0.82
Concise review: Engineering myocardial tissue: the convergence of stem cells biology and tissue engineering technology. Stem Cells (2013) 0.81
Embryonic stem cells overexpressing Pitx2c engraft in infarcted myocardium and improve cardiac function. Int Heart J (2009) 0.80
Marching towards regenerative cardiac therapy with human pluripotent stem cells. Discov Med (2013) 0.80
Enhanced engraftment, proliferation, and therapeutic potential in heart using optimized human iPSC-derived cardiomyocytes. Sci Rep (2016) 0.79
Lost in translation: what is limiting cardiomyoplasty and can tissue engineering help? Curr Stem Cell Res Ther (2009) 0.79
Current progress with primate embryonic stem cells. Curr Stem Cell Res Ther (2006) 0.79
Optimizing stem cells for cardiac repair: Current status and new frontiers in regenerative cardiology. World J Stem Cells (2017) 0.78
Adhesion proteins, stem cells, and arrhythmogenesis. Cardiovasc Toxicol (2008) 0.78
Introduction to stem cell therapy. J Cardiovasc Nurs (2009) 0.78
Fate of modular cardiac tissue constructs in a syngeneic rat model. J Tissue Eng Regen Med (2013) 0.78
Human cardiomyogenesis and the need for systems biology analysis. Wiley Interdiscip Rev Syst Biol Med (2010) 0.78
In Vivo Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Neonatal and Adult Rat Hearts. Stem Cell Reports (2016) 0.78
Engineered heart tissue graft derived from somatic cell nuclear transferred embryonic stem cells improve myocardial performance in infarcted rat heart. J Cell Mol Med (2010) 0.77
Minimally invasive cell-seeded biomaterial systems for injectable/epicardial implantation in ischemic heart disease. Int J Nanomedicine (2012) 0.77
Bioluminescent imaging of genetically selected induced pluripotent stem cell-derived cardiomyocytes after transplantation into infarcted heart of syngeneic recipients. PLoS One (2014) 0.77
Progenitor/stem cell transplantation for repair of myocardial infarction: Hype or hope? Ann Palliat Med (2012) 0.77
Myoblasts and embryonic stem cells differentially engraft in a mouse model of genetic dilated cardiomyopathy. Mol Ther (2013) 0.77
Striated muscle function, regeneration, and repair. Cell Mol Life Sci (2016) 0.76
Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes as a Model for Heart Development and Congenital Heart Disease. Stem Cell Rev (2015) 0.76
Cardiac engraftment of genetically-selected parthenogenetic stem cell-derived cardiomyocytes. PLoS One (2015) 0.76
Methods for assessing the electromechanical integration of human pluripotent stem cell-derived cardiomyocyte grafts. Methods Mol Biol (2014) 0.76
Arrhythmia in stem cell transplantation. Card Electrophysiol Clin (2015) 0.76
Current protocols in the generation of pluripotent stem cells: theoretical, methodological and clinical considerations. Stem Cells Cloning (2009) 0.76
Electrical effects of stem cell transplantation for ischaemic cardiomyopathy: friend or foe? J Physiol (2016) 0.76
HLA Class I Depleted hESC as a Source of Hypoimmunogenic Cells for Tissue Engineering Applications. Tissue Eng Part A (2015) 0.76
Simulated Microgravity and 3D Culture Enhance Induction, Viability, Proliferation and Differentiation of Cardiac Progenitors from Human Pluripotent Stem Cells. Sci Rep (2016) 0.75
In vivo Evaluation of Human Embryonic Stem Cells Isolated by 57-C11 Monoclonal Antibody. Int J Stem Cells (2016) 0.75
Cryopreservation of Human Pluripotent Stem Cell-Derived Cardiomyocytes: Strategies, Challenges, and Future Directions. Adv Exp Med Biol (2016) 0.75
Multipotency and cardiomyogenic potential of human adipose-derived stem cells from epicardium, pericardium, and omentum. Stem Cell Res Ther (2016) 0.75
Prosurvival Factors Improve Functional Engraftment of Myogenically Converted Dermal Cells into Dystrophic Skeletal Muscle. Stem Cells Dev (2016) 0.75
Embryonic stem cell lines derived from human blastocysts. Science (1998) 65.53
Bone marrow cells regenerate infarcted myocardium. Nature (2001) 21.24
Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell (2003) 18.09
The Ki-67 protein: from the known and the unknown. J Cell Physiol (2000) 16.48
Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol (2001) 11.53
Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature (2004) 8.87
Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med (2003) 8.46
Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature (2004) 8.36
Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation (2002) 7.97
Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A (2003) 7.87
Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature (2002) 7.28
Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation (2002) 7.14
Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest (2001) 6.59
Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A (2000) 6.59
Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature (2003) 6.35
Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation (2003) 6.30
Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ Res (2003) 5.12
Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol (2004) 4.50
Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. J Clin Invest (1996) 3.87
Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J Mol Cell Cardiol (2002) 3.79
Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res (2002) 3.69
Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol (2001) 3.66
Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg (2002) 3.62
Role of the human heat shock protein hsp70 in protection against stress-induced apoptosis. Mol Cell Biol (1997) 3.39
Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science (1994) 3.24
Overexpression of the rat inducible 70-kD heat stress protein in a transgenic mouse increases the resistance of the heart to ischemic injury. J Clin Invest (1995) 2.97
Stress (heat shock) proteins: molecular chaperones in cardiovascular biology and disease. Circ Res (1998) 2.89
Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. Circulation (1999) 2.68
Stem cell differentiation requires a paracrine pathway in the heart. FASEB J (2002) 2.55
Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J Mol Cell Cardiol (2002) 2.29
Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci U S A (2003) 2.21
Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest (1996) 2.20
Significant improvement of heart function by cotransplantation of human mesenchymal stem cells and fetal cardiomyocytes in postinfarcted pigs. Ann Thorac Surg (2002) 1.84
Electromechanical coupling between skeletal and cardiac muscle. Implications for infarct repair. J Cell Biol (2000) 1.66
Myocyte and myogenic stem cell transplantation in the heart. Cardiovasc Res (2003) 1.66
Dissociated spatial patterning of gap junctions and cell adhesion junctions during postnatal differentiation of ventricular myocardium. Circ Res (1997) 1.63
Scalable production of embryonic stem cell-derived cardiomyocytes. Tissue Eng (2003) 1.44
Cardiomyocyte differentiation of mouse and human embryonic stem cells. J Anat (2002) 1.38
Antibodies defining rat endothelial cells: RECA-1, a pan-endothelial cell-specific monoclonal antibody. Lab Invest (1992) 1.37
Evidence for fusion between cardiac and skeletal muscle cells. Circ Res (2004) 1.34
Cardioprotective effects of 70-kDa heat shock protein in transgenic mice. Proc Natl Acad Sci U S A (1996) 1.32
Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction. Circulation (2001) 1.25
DNA synthesis and multinucleation in embryonic stem cell-derived cardiomyocytes. Am J Physiol (1995) 1.21
Transmural replacement of myocardium after skeletal myoblast grafting into the heart. Too much of a good thing? Cardiovasc Pathol (2001) 1.16
Heat shock protein 70 gene transfection protects mitochondrial and ventricular function against ischemia-reperfusion injury. Circulation (2001) 1.15
Human heat shock protein 70 (hsp70) protects murine cells from injury during metabolic stress. J Clin Invest (1993) 1.15
Influence of embryonic cardiomyocyte transplantation on the progression of heart failure in a rat model of extensive myocardial infarction. J Mol Cell Cardiol (2001) 1.14
Transplantation of cells for cardiac repair. J Am Coll Cardiol (2003) 1.09
Distribution pattern of alpha and beta myosin in normal and diseased human ventricular myocardium. Basic Res Cardiol (1989) 1.02
Constitutive and inducible hsp70s are involved in oxidative resistance evoked by heat shock or ethanol. J Mol Cell Cardiol (1998) 1.00
Stem cell therapy for ischemic heart disease. Trends Mol Med (2003) 0.96
Development changes in the human cardiac isomyosin distribution: an immunohistochemical study using monoclonal antibodies. Circ Res (1987) 0.94
Cellular therapies for myocardial infarct repair. Cold Spring Harb Symp Quant Biol (2002) 0.91
Distribution of alpha- and beta-myosin heavy chains in the ventricular fibers of the postnatal developing rat. Dev Biol (1987) 0.90
Autologous cell transplantation for the treatment of damaged myocardium. Prog Cardiovasc Dis (2002) 0.85
Glycogen content in human embryonic heart. Recent Adv Stud Cardiac Struct Metab (1975) 0.79
Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol (2007) 14.48
Truncations of titin causing dilated cardiomyopathy. N Engl J Med (2012) 6.07
Heart regeneration. Nature (2011) 5.91
Regenerating the heart. Nat Biotechnol (2005) 5.58
Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J (2007) 4.32
Biphasic role for Wnt/beta-catenin signaling in cardiac specification in zebrafish and embryonic stem cells. Proc Natl Acad Sci U S A (2007) 3.90
Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res (2002) 3.69
Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature (2012) 3.63
Growth of engineered human myocardium with mechanical loading and vascular coculture. Circ Res (2011) 3.25
A hierarchical network controls protein translation during murine embryonic stem cell self-renewal and differentiation. Cell Stem Cell (2008) 3.18
rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice. Nat Med (2006) 3.13
Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts. Circ Res (2002) 2.94
A temporal chromatin signature in human embryonic stem cells identifies regulators of cardiac development. Cell (2012) 2.81
Systems approaches to preventing transplanted cell death in cardiac repair. J Mol Cell Cardiol (2008) 2.60
Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation. Nat Biotechnol (2004) 2.60
Proangiogenic scaffolds as functional templates for cardiac tissue engineering. Proc Natl Acad Sci U S A (2010) 2.58
Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes. Circ Res (2014) 2.34
Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J Mol Cell Cardiol (2002) 2.29
Extracardiac progenitor cells repopulate most major cell types in the transplanted human heart. Circulation (2005) 2.29
Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair. Am J Pathol (2003) 2.22
Basic fibroblast growth factor supports undifferentiated human embryonic stem cell growth without conditioned medium. Stem Cells (2005) 2.09
Endogenous Wnt/beta-catenin signaling is required for cardiac differentiation in human embryonic stem cells. PLoS One (2010) 2.06
Cell-based therapy for myocardial ischemia and infarction: pathophysiological mechanisms. Annu Rev Pathol (2007) 1.86
Proliferation of cardiomyocytes derived from human embryonic stem cells is mediated via the IGF/PI 3-kinase/Akt signaling pathway. J Mol Cell Cardiol (2005) 1.78
Upregulation of cardiomyocyte ribonucleotide reductase increases intracellular 2 deoxy-ATP, contractility, and relaxation. J Mol Cell Cardiol (2011) 1.72
VEGF induces differentiation of functional endothelium from human embryonic stem cells: implications for tissue engineering. Arterioscler Thromb Vasc Biol (2009) 1.57
Fibroblast growth factor-2 regulates myocardial infarct repair: effects on cell proliferation, scar contraction, and ventricular function. Am J Pathol (2007) 1.43
Scaffold-free human cardiac tissue patch created from embryonic stem cells. Tissue Eng Part A (2009) 1.42
In vitro generation of differentiated cardiac myofibers on micropatterned laminin surfaces. J Biomed Mater Res (2002) 1.38
Bones of contention: marrow-derived cells in myocardial regeneration. J Mol Cell Cardiol (2008) 1.37
Efficient generation and cryopreservation of cardiomyocytes derived from human embryonic stem cells. Regen Med (2011) 1.35
Cardiac bodies: a novel culture method for enrichment of cardiomyocytes derived from human embryonic stem cells. Stem Cells Dev (2006) 1.35
Evidence for fusion between cardiac and skeletal muscle cells. Circ Res (2004) 1.34
NFATc3-induced reductions in voltage-gated K+ currents after myocardial infarction. Circ Res (2004) 1.33
Myogenic fusion of human bone marrow stromal cells, but not hematopoietic cells. Blood (2004) 1.29
Progenitor cells identified by PDGFR-alpha expression in the developing and diseased human heart. Stem Cells Dev (2013) 1.19
Myostatin represses physiological hypertrophy of the heart and excitation-contraction coupling. J Physiol (2009) 1.19
Spatially organized layers of cardiomyocytes on biodegradable polyurethane films for myocardial repair. J Biomed Mater Res A (2003) 1.19
Chromatin remodeling during mouse and human embryonic stem cell differentiation. Dev Dyn (2008) 1.18
Ferritin overexpression for noninvasive magnetic resonance imaging-based tracking of stem cells transplanted into the heart. Mol Imaging (2010) 1.16
Taking the death toll after cardiomyocyte grafting: a reminder of the importance of quantitative biology. J Mol Cell Cardiol (2002) 1.16
Human embryonic stem cells and cardiac repair. Transplant Rev (Orlando) (2008) 1.15
Delivery of basic fibroblast growth factor with a pH-responsive, injectable hydrogel to improve angiogenesis in infarcted myocardium. Biomaterials (2010) 1.15
Human embryonic stem cell-derived cardiomyocytes can be maintained in defined medium without serum. Stem Cells Dev (2006) 1.15
Immunohistologic labeling of murine endothelium. Cardiovasc Pathol (2003) 1.15
Measuring the contractile forces of human induced pluripotent stem cell-derived cardiomyocytes with arrays of microposts. J Biomech Eng (2014) 1.08
Human embryonic stem cells differentiated to lung lineage-specific cells ameliorate pulmonary fibrosis in a xenograft transplant mouse model. PLoS One (2012) 1.08
Cell therapy enhances function of remote non-infarcted myocardium. J Mol Cell Cardiol (2009) 1.07
Developing vasculature and stroma in engineered human myocardium. Tissue Eng Part A (2011) 1.07
Absence of regeneration in the MRL/MpJ mouse heart following infarction or cryoinjury. Cardiovasc Pathol (2007) 1.05
Chemical target and pathway toxicity mechanisms defined in primary human cell systems. J Pharmacol Toxicol Methods (2009) 1.04
Cardiogenesis from human embryonic stem cells. Circ J (2010) 1.00
Targeted genomic integration of a selectable floxed dual fluorescence reporter in human embryonic stem cells. PLoS One (2012) 1.00
Improving access to mental health care for children: the Massachusetts Child Psychiatry Access Project. Pediatrics (2010) 1.00
Gene transfer of connexin43 into skeletal muscle. Hum Gene Ther (2004) 0.99
Re-evaluation of the carcinogenic significance of hepatitis B virus integration in hepatocarcinogenesis. PLoS One (2012) 0.96
Chemical dimerization of fibroblast growth factor receptor-1 induces myoblast proliferation, increases intracardiac graft size, and reduces ventricular dilation in infarcted hearts. Hum Gene Ther (2007) 0.96
Improving survival and efficacy of pluripotent stem cell-derived cardiac grafts. J Cell Mol Med (2013) 0.96
Characteristics and PD-1 expression of peripheral CD4+CD127loCD25hiFoxP3+ Treg cells in chronic HCV infected-patients. Virol J (2011) 0.96
Cell grafting for cardiac repair. Methods Mol Biol (2003) 0.95
Effects of cell grafting on coronary remodeling after myocardial infarction. J Am Heart Assoc (2013) 0.95
Allopurinol/uricase and ibuprofen enhance engraftment of cardiomyocyte-enriched human embryonic stem cells and improve cardiac function following myocardial injury. Eur J Cardiothorac Surg (2005) 0.95
Evaluating the genomic and sequence integrity of human ES cell lines; comparison to normal genomes. Stem Cell Res (2011) 0.94
Is it possible to transform cardiac scar tissue into beating heart muscle in humans? Regen Med (2012) 0.94
Quantitative methylation analysis reveals gender and age differences in p16INK4a hypermethylation in hepatitis B virus-related hepatocellular carcinoma. Liver Int (2011) 0.94
Monocyte chemoattractant protein 1-mediated migration of mesenchymal stem cells is a source of intimal hyperplasia. Arterioscler Thromb Vasc Biol (2013) 0.94
Transmembrane protein 88: a Wnt regulatory protein that specifies cardiomyocyte development. Development (2013) 0.94
Comparison of Human Embryonic Stem Cell-Derived Cardiomyocytes, Cardiovascular Progenitors, and Bone Marrow Mononuclear Cells for Cardiac Repair. Stem Cell Reports (2015) 0.93
Heart regeneration with engineered myocardial tissue. Annu Rev Biomed Eng (2014) 0.93
Transgenic overexpression of ribonucleotide reductase improves cardiac performance. Proc Natl Acad Sci U S A (2013) 0.92
The role of macrophage-derived urokinase plasminogen activator in myocardial infarct repair: urokinase attenuates ventricular remodeling. J Mol Cell Cardiol (2010) 0.92
Nanotopography-Induced Structural Anisotropy and Sarcomere Development in Human Cardiomyocytes Derived from Induced Pluripotent Stem Cells. ACS Appl Mater Interfaces (2016) 0.90
An improved cryosection method for polyethylene glycol hydrogels used in tissue engineering. Tissue Eng Part C Methods (2013) 0.89
Engineered human cardiac tissue. Pediatr Cardiol (2011) 0.89
P³DB 3.0: From plant phosphorylation sites to protein networks. Nucleic Acids Res (2013) 0.88
PD-1 expression on peripheral CD8+ TEM/TEMRA subsets closely correlated with HCV viral load in chronic hepatitis C patients. Virol J (2010) 0.87
Regenerative medicine: Reprogramming the injured heart. Nature (2012) 0.87
Bridging the divide between child psychiatry and primary care: the use of telephone consultation within a population-based collaborative system. Child Adolesc Psychiatr Clin N Am (2011) 0.86
Differentiation of cardiomyocytes from human embryonic stem cells is accompanied by changes in the extracellular matrix production of versican and hyaluronan. J Cell Biochem (2010) 0.86
Quantification of MRI signal of transgenic grafts overexpressing ferritin in murine myocardial infarcts. NMR Biomed (2012) 0.86
Evidence that gene activation and silencing during stem cell differentiation requires a transcriptionally paused intermediate state. PLoS One (2011) 0.85
CCND1 G870A polymorphism with altered cyclin D1 transcripts expression is associated with the risk of glioma in a Chinese population. DNA Cell Biol (2012) 0.85
Thermoresponsive nanofabricated substratum for the engineering of three-dimensional tissues with layer-by-layer architectural control. ACS Nano (2014) 0.84
A higher correlation of HCV core antigen with CD4+ T cell counts compared with HCV RNA in HCV/HIV-1 coinfected patients. PLoS One (2011) 0.84
Lack of thrombospondin-2 reduces fibrosis and increases vascularity around cardiac cell grafts. Cardiovasc Pathol (2012) 0.83